349 related articles for article (PubMed ID: 22738661)
1. Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.
Wang B; Yu H; Yang FR; Huang M; Ma JH; Tong GZ
Virol J; 2012 Jun; 9():127. PubMed ID: 22738661
[TBL] [Abstract][Full Text] [Related]
2. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
3. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
Kim KH; Jung YJ; Lee Y; Park BR; Oh J; Lee YN; Kim MC; Jeeva S; Kang SM
Virology; 2020 Nov; 550():51-60. PubMed ID: 32882637
[TBL] [Abstract][Full Text] [Related]
4. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
5. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
[TBL] [Abstract][Full Text] [Related]
6. A novel M2e-multiple antigenic peptide providing heterologous protection in mice.
Wen F; Ma JH; Yu H; Yang FR; Huang M; Zhou YJ; Li ZJ; Wang XH; Li GX; Jiang YF; Tong W; Tong GZ
J Vet Sci; 2016 Mar; 17(1):71-8. PubMed ID: 27051342
[TBL] [Abstract][Full Text] [Related]
7. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
[TBL] [Abstract][Full Text] [Related]
8. Universal Live-Attenuated Influenza Vaccine Candidates Expressing Multiple M2e Epitopes Protect Ferrets against a High-Dose Heterologous Virus Challenge.
Mezhenskaya D; Isakova-Sivak I; Matyushenko V; Donina S; Rekstin A; Sivak K; Yakovlev K; Katelnikova A; Kryshen K; Makarov V; Rudenko L
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209093
[TBL] [Abstract][Full Text] [Related]
9. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
Wang W; Li R; Deng Y; Lu N; Chen H; Meng X; Wang W; Wang X; Yan K; Qi X; Zhang X; Xin W; Lu Z; Li X; Bian T; Gao Y; Tan W; Ruan L
Clin Vaccine Immunol; 2015 Jun; 22(6):618-30. PubMed ID: 25834017
[TBL] [Abstract][Full Text] [Related]
10. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
[TBL] [Abstract][Full Text] [Related]
11. Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
Kim J; Chang J
Vaccine; 2024 May; 42(15):3505-3513. PubMed ID: 38714444
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
Park BR; Subbiah J; Kim KH; Kwon YM; Oh J; Kim MC; Shin CH; Seong BL; Kang SM
Virology; 2022 Jan; 566():143-152. PubMed ID: 34929590
[TBL] [Abstract][Full Text] [Related]
13. A chimeric influenza hemagglutinin delivered by parainfluenza virus 5 vector induces broadly protective immunity against genetically divergent influenza a H1 viruses in swine.
Li Z; Zaiser SA; Shang P; Heiden DL; Hajovsky H; Katwal P; DeVries B; Baker J; Richt JA; Li Y; He B; Fang Y; Huber VC
Vet Microbiol; 2020 Nov; 250():108859. PubMed ID: 33039727
[TBL] [Abstract][Full Text] [Related]
14. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
[TBL] [Abstract][Full Text] [Related]
15. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.
Heinen PP; Rijsewijk FA; de Boer-Luijtze EA; Bianchi ATJ
J Gen Virol; 2002 Aug; 83(Pt 8):1851-1859. PubMed ID: 12124449
[TBL] [Abstract][Full Text] [Related]
17. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
18. Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.
Sisteré-Oró M; Vergara-Alert J; Stratmann T; López-Serrano S; Pina-Pedrero S; Córdoba L; Pérez-Maillo M; Pleguezuelos P; Vidal E; Veljkovic V; Segalés J; Nielsen J; Fomsgaard A; Darji A
PLoS One; 2019; 14(3):e0212431. PubMed ID: 30822308
[TBL] [Abstract][Full Text] [Related]
19. Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.
Yao Y; Wang H; Chen J; Shao Z; He B; Chen J; Lan J; Chen Q; Chen Z
Emerg Microbes Infect; 2019; 8(1):45-54. PubMed ID: 30866759
[TBL] [Abstract][Full Text] [Related]
20. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
